Search results
Defining AF Cardiomyopathy
Author(s):
Nikhil Ahluwalia
,
Shohreh Honarbakhsh
,
Ross Hunter
,
et al
Added:
1 week ago
Review Article
Author(s):
Elena Arbelo
Added:
3 months ago
Understand the evolving landscape of arrhythmogenic cardiomyopathy (ACM) risk stratification and ICD decision-making with Prof Elena ArbeloThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical shift from phenotype-based to genotype-informed risk assessment in arrhythmogenic cardiomyopathy management, addressing the significant challenge that over half of…
View more
Author(s):
Valentina Kutyifa
Added:
10 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of…
View more
LB-NICM: New Approach
Author(s):
Shunmuga Sundaram Ponnusamy
,
Pugazhendhi Vijayaraman
,
Kenneth Ellenbogen
Added:
1 year ago
Review Article
Ventricular Tachycardia After Cardioversion
Author(s):
Eiad Habib
,
Mahmoud Abdelnabi
,
Ramzi Ibrahim
,
et al
Added:
3 months ago
Case Report
Author(s):
Demosthenes G Katritsis
,
Robert H Anderson
Added:
5 days ago
Added:
1 week ago
Source:
Radcliffe Cardiology
Explore free-to-access cardiology content, including expert video discussions, guideline-relevant analysis and peer-reviewed reviews designed for application in cardiovascular practice.New Horizons in Dyslipidaemia 2026On-Demand Video EventWith forthcoming updates anticipated at American College of Cardiology Annual Scientific Session, dyslipidaemia management is entering a period of refinement,…
View more
Juan Pablo Ochoa
Author
Added:
1 month ago
Source:
Radcliffe Cardiology
For patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), the net effect of right ventricular pacing (RVP) has been variable, as it can reduce the left ventricular outflow tract gradient (LVOTg) but may also decrease cardiac output.¹ The EMORI-HCM trial investigated whether electromechanically optimising the atrio-ventricular delay (AVD) could allow RVP to achieve a consistent…
View more
Author(s):
Ahran D Arnold
Added:
6 months ago
ESC Congress 2025 - EMORI-HCM finds that right ventricular pacing (iRVP) improves symptoms in obstructive hypertrophic cardiomyopathy (oHCM) patients.Dr Ahran Arnold (Imperial College London, UK) discusses findings from the EMORI-HCM study, exploring electro-mechanically optimised right ventricular pacing as a novel therapeutic approach for patients with oHCM.This interventional trial examined…
View more